These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33333040)

  • 21. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
    Brandman D; Boyle M; McPherson S; Van Natta ML; Sanyal AJ; Kowdley K; Neuschwander-Tetri B; Chalasani N; Abdelmalek MF; Terrault NA; McCullough A; Bettencourt R; Caussy C; Kleiner DE; Behling C; Tonascia J; Anstee QM; Loomba R;
    Aliment Pharmacol Ther; 2022 Jun; 55(11):1441-1451. PubMed ID: 35302256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MACK-3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis.
    Chuah KH; Wan Yusoff WNI; Sthaneshwar P; Nik Mustapha NR; Mahadeva S; Chan WK
    Liver Int; 2019 Jul; 39(7):1315-1324. PubMed ID: 30825254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.
    Mohammed MA; Omar NM; Mohammed SA; Amin AM; Gad DF
    Pak J Biol Sci; 2019 Jan; 22(10):457-466. PubMed ID: 31930835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis.
    Okanoue T; Ebise H; Kai T; Mizuno M; Shima T; Ichihara J; Aoki M
    J Gastroenterol; 2018 Jan; 53(1):129-139. PubMed ID: 28589339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Balakrishnan M; Seth A; Cortes-Santiago N; Jain S; Sood GK; El-Serag HB; Thrift AP
    Dig Dis Sci; 2021 Jul; 66(7):2387-2393. PubMed ID: 32757159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
    Jun DW; Kim SG; Park SH; Jin SY; Lee JS; Lee JW; Kim MY; Choi DH; Cho YK; Yeon JE; Sohn JH;
    J Gastroenterol Hepatol; 2017 May; 32(5):1094-1099. PubMed ID: 27859583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
    Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
    Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study.
    Huang DQ; Ahlholm N; Luukkonen PK; Porthan K; Amangurbanova M; Madamba E; Bettencourt R; Siddiqi H; Cervantes V; Hernandez C; Lopez SJ; Richards L; Nemes K; Isoniemi H; Yki-Järvinen H; Loomba R
    Clin Gastroenterol Hepatol; 2024 Jan; 22(1):81-90.e4. PubMed ID: 37406954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease.
    Hagström H; Nasr P; Ekstedt M; Stål P; Hultcrantz R; Kechagias S
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1148-1156.e4. PubMed ID: 30471458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
    Wang A; Blackford AL; Behling C; Wilson LA; Newton KP; Xanthakos SA; Fishbein MH; Vos MB; Mouzaki M; Molleston JP; Jain AK; Hertel P; Harlow Adams K; Schwimmer JB;
    Hepatology; 2024 Jun; 79(6):1381-1392. PubMed ID: 37870272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.
    Demir M; Lang S; Nierhoff D; Drebber U; Hardt A; Wedemeyer I; Schulte S; Quasdorff M; Goeser T; Töx U; Steffen HM
    J Clin Gastroenterol; 2013 Sep; 47(8):719-26. PubMed ID: 23442837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
    Younes R; Rosso C; Petta S; Cucco M; Marietti M; Caviglia GP; Ciancio A; Abate ML; Cammà C; Smedile A; Craxì A; Saracco GM; Bugianesi E
    Liver Int; 2018 Apr; 38(4):715-723. PubMed ID: 29028281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
    Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M
    Liver Int; 2015 Aug; 35(8):2027-35. PubMed ID: 25495478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Yang X; Xia M; Chang X; Zhu X; Sun X; Yang Y; Wang L; Liu Q; Zhang Y; Xu Y; Lin H; Liu L; Yao X; Hu X; Gao J; Yan H; Gao X; Bian H
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3570. PubMed ID: 35938229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.